ADDITIONAL INFO

MT-II Spray (MT-2) — Cyclic α-MSH Analog Research Peptide

MT-II Spray is a synthetic research peptide delivering a cyclic α-MSH analog optimized for melanocortin receptor studies. It is widely utilized in laboratory settings to investigate MC1R, MC3R, and MC4R receptor signaling, pigmentation pathways, and neuroendocrine modulation. The intranasal delivery format enables researchers to examine bioavailability, receptor specificity, and alternate delivery mechanisms in in-vitro neurochemical and receptor studies.

Concentration: 10 mg/100 mcg per spray

For research use only. Not for human or animal consumption.

Product Details

Compound Name: MT-II (α-MSH cyclic analog)
Net Contents: 10 mg per bottle
Form: Intranasal spray
Purity: ≥98% (Certificate of Analysis available)
Primary Targets: MC1R, MC3R, MC4R melanocortin receptors, pigmentation pathways, neuroendocrine signaling
Manufactured in: GMP-compliant facility
Intended Use: Laboratory research use only — not for human or veterinary use

Storage & Handling

• Store sealed at 2–8 °C, protected from light

• Do not freeze unless stability data specifies

• Allow container to reach room temperature before use

• Maintain sterile handling conditions during research procedures

• Avoid repeated temperature fluctuations

• Consult SDS for complete safety guidance

Research Applications

MT-II Spray is commonly used in laboratory studies to investigate:

• Melanocortin receptor signaling (MC1R, MC3R, MC4R)

• Pigmentation pathways and melanogenesis

• Neuroendocrine and behavioral modulation

• Peptide–receptor interactions and specificity

• Intranasal delivery bioavailability and alternative delivery mechanisms